Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 11 to 14 amino acid residues in defined sequence
Reexamination Certificate
2006-12-05
2006-12-05
Borin, Michael (Department: 1631)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
11 to 14 amino acid residues in defined sequence
C530S300000, C514S014800, C514S015800
Reexamination Certificate
active
07144982
ABSTRACT:
Polypeptides and methods of use including treating bacterial infection and/or endotoxemia, decreasing the amount of TNF-α, inhibiting endothelial cell proliferation, inhibiting angiogenic-factor mediated inter-cellular adhesion molecule expression down-regulation, and inhibiting angiogenesis.
REFERENCES:
patent: 4938949 (1990-07-01), Borch et al.
patent: 5595887 (1997-01-01), Coolidge et al.
patent: 5786324 (1998-07-01), Gray et al.
patent: 5830860 (1998-11-01), Gray et al.
patent: 5837678 (1998-11-01), Little, II
patent: 5854214 (1998-12-01), Little, II
patent: 5856302 (1999-01-01), Ammons et al.
patent: 5955577 (1999-09-01), Mayo
patent: 0 955 312 (1999-11-01), None
patent: WO 99/17616 (1999-04-01), None
patent: WO 01/53335 (2001-07-01), None
Olee et al. Database Caplus, Journal of Neuroimmunology (1989), 21(2-3), 235-40.
Ngo et al . In: The protein folding and tertiary structure prediction, K. Mertz and S. Le Grand, Eds. Birkhauser, Boston, 1994, pp. 491-495.
Agerberth et al., “Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides,”European Journal of Biochemistry, 202(3):849-854 (1991).
Alvarez-Bravo et al., “Mode of Action of an Antibacterial Peptide, KLKLLLLLKLK-NH2,”The Journal of Biochemistry(Tokyo ), 117(6):1312-1316 (1995).
Andreu et al., “N-Terminal Analogues of Cecropin A: Synthesis, Antibacterial Activity, and Conformational Properties,”Biochemistry, 24(7):1683-1688 (1985).
Andreu et al., “Animal Antimicrobial Peptides: An Overview.”Biopolymers Peptide Science, 47(6):415-433 (1998).
Griffioen et al., “Endothelial Intercellular Adhesion Molecule-1 Expression Is Suppressed in Human Malignancies: The Role of Angiogenic Factors,”Cancer Research, 56(5):1111-1117 (1996).
Griffioen et al., “Tumor Angiogenesis Is Accompanied by a Decreased Inflammatory Response of Tumor-Associated Endothelium,”Blood, 88(2):667-673 (1996).
Griffioen et al., “Angiogenesis, a target for tumor therapy,”Journal of Laboratory and Clinical Medicine, 132(5):363-368 (1998).
Griffioen et al., “Angiogenesis inhibitors overcome tumor induced endothelial cell anergy,”International Journal of Cancer, 80(2):315-319 (1999).
Groenewegen et al., “Supernatants of human leukocytes contain mediator, different from interferon γ, which induces expression of MHC class II antigens,”The Journal of Experimental Medicine, 164(1):131-143 (1986).
Hanzawa et al., “1H nuclear magnetic resonance study of the solution conformation of an antibacterial protein, sapecin,”FEBS Letters, 269(2):413-420 (1990).
Heumann et al., “Competition between Bactericidal/Permeability-Increasing Protein and Lipopolysaccharide-Binding Protein for Lipopolysaccharide Binding to Monocytes,”The Journal of Infectious Diseases, 167(6):1351-1357 (1993).
Hill et al., “Crystal Structure of Defensin HNP-3, an Amphiphilic Dimer: Mechanisms of Membrane Permeabilization,”Science, 251(5000):1481-1485 (1991).
Hoess et al., “Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab,Limulusanti-LPS factor, at 1.5 {dot over (A)} resolution,”EMBO Journal, 12(9):3351-3356 (1993).
Holak et al., “The Solution Conformation of the Antibacterial Peptide Cecropin A: A Nuclear Magnetic Resonance and Dynamical Simulated Annealing Study,”Biochemistry, 27(20):7620-7629 (1988).
Homma, “A New Antigenic Schema and Live-cell Slide-agglutination Procedure for the Infrasubspecific, Serologic Classification ofPseudomonas aeruginosa,” The Japanese Journal of Experimental Medicine, 46(6):329-336 (1976).
Hovde et al., “Characterization of a Protein from Normal Human Polymorphonuclear Leukocytes with Bactericidal Activity againstPseudomonas aeruginosa, ” Infection and Immunity, 54(1):142-148 (1986).
Ilyina et al., “NMR Structure of ade NovoDesigned, Peptide 33mer with Two Distinct, Compact β-Sheet Folds,”Biochemistry, 36(17):5245-5250 (1997).
Johnson, Jr., “Protein Secondary Structure and Circular Dichroism: A Practical Guide,”Proteins: Structure, Function, and Genetics, 7(3):205-214 (1990).
Johnson et al., “Defining Inoculation Conditions for the Mouse Model of Ascending Urinary Tract Infection that Avoid Immediate Vesicoureteral Reflux yet Produce Renal and Bladder Infection,”The Journal of Infectious Diseases, 173(3):746-749 (1996).
Johnson et al., “A Novel Multiply Primed Polymerase Chain Reaction Assay for Identification of VariantpapGGenes Encoding the Gal(α1-4)Gal-Binding PapG Adhesins ofEscherichia coli,” The Journal of Infectious Diseases, 173(4):920-926 (1996).
Kawano et al., “Antimicrobial Peptide, Tachyplesin I, Isolated from Hemocytes of the Horseshoe Crab (Tachypleus tridentatus). NMR determination of the β-sheet structure,”The Journal of Biological Chemistry, 265(26):15365-15367 (1990).
Kelly et al., “Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia,”Surgery, 114(2):140-146 (1993).
Kitayama et al., “Suppressive Effect of Basic Fibroblast Growth Factor on Transendothelial Emigration of CD4(+) T-Lymphocyte,”Cancer Research, 54(17):4729-4733 (1994).
Koning et al., “Calculation of the Nuclear Overhauser Effect and the Determination of Proton—Proton Distances in the Presence of Internal Motions,”Journal of Magnetic Resonance, 90(1):111-123 (1990).
Lee et al., “Antibacterial peptides from pig intestine: Isolation of a mammalian cecropin,”Proceedings of the National Academy of Sciences(USA). 86(23):9159-9162 (1989).
Lehrer et al., “Defensins: Endogenous Antibiotic Peptides of Animal Cells,”Cell, 64(2):229-230 (1991).
Little et al., “Functional Domains of Recombinant Bactericidal/Permeability Increasing Protein (rBPI23),”The Journal of Biological Chemistry, 269(3):1865-1872 (1994).
Maloy et al., “Structure-Activity Studies on Magainins and Other Host defense Peptides,”Biopolymers Peptide Science, 37(2):105-122 (1995).
Marion et al., “Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of1H—1H spin—spin coupling constants in proteins,”Biochemical and Biophysical Research Communications, 113(3):967-974 (1983).
Marion et al., “A two-dimensional NMR study of the antimicrobial peptide magainin 2,”FEBS Letters, 227(1):21-26 (1988).
Marra et al., “Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity,”The Journal of Immunology, 144(2):662-666 (1990).
Marra et al., “The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin,”The Journal of Immunology, 148(2):532-537 (1992).
Matsuyama et al., “Purification of Three Antibacterial Proteins from the Culture Medium of NIH-Sape-4, an Embryonic Cell Line ofSarcophaga peregrina,” The Journal of Biological Chemistry, 263(32):17112-17116 (1988).
Matsuzaki et al., “Modulation of Magainin 2-Lipid Bilayer Interactions by Peptide Charge,”Biochemistry, 36(8):2104-2111 (1997).
Mayo et al., “A recipe for designing water-soluble, β-sheet-forming peptides,”Protein Science, 5(7):1301-1315 (1996).
Mayo et al., “Designed β-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities,”Biochimica et Biophysica Acta, 1425(1):81-92 (1998).
Mayo et al., “Structure-function relationships in novel peptide dodecamers with broad-spectrum bactericidal and endotoxin-neutralizing activities,”Biochemical Journal, 349(3):717-728 (2000).
Melder et al., “During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor re
Borin Michael
Mueting Raasch & Gebhardt, P.A.
University of Minnesota
LandOfFree
Polypeptides with therapeutic activity and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides with therapeutic activity and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides with therapeutic activity and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3717626